Clinical trials and case report

The goal of research on the dementia is to develop the medicine to recover them from the problem. It is occurred in all over the world. The clinical trials are done to check whether this method is safe or unsafe for the patient. Without the clinical research and care taker there is no treatment for the dementia.

Medications called cholinesterase inhibitors are prescribed for mild to moderate dementia diseases. These drugs may help to cure the problem or suppress the problem. There is no standard treatment for dementia, but some of the measures to maintain the mental state of the patient.

Aducanumab is a monoclonal antibody an expensive drug to cure the dementia diseases. Function behind this method is that protein molecule bind with the drug to cure them. It is given through the intravenous vein once in a month. 

  • Track 1-1 Aducanumab
  • Track 2-2 cholinesterase inhibitors

Related Conference of Neuroscience